Citation Impact
Citing Papers
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
2010
Hierarchical design of pseudosymmetric protein nanocages
2024 StandoutNatureNobel
Integrative genomic mining for enzyme function to enable engineering of a non-natural biosynthetic pathway
2015 StandoutNobel
Tilt-Pair Analysis of Images from a Range of Different Specimens in Single-Particle Electron Cryomicroscopy
2011 StandoutNobel
The humanization of N-glycosylation pathways in yeast
2005
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Getting the glycosylation right: Implications for the biotechnology industry
1996
Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules
2009
suc1 is an essential gene involved in both the cell cycle and growth in fission yeast
1986 StandoutNobel
Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env
2011
Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors: Special reference to nonmucus producing lung adenocarcinomas
1988 StandoutNobel
Synthesis of mumps virus nucleocapsid protein in yeast Pichia pastoris
2003
Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells
2011
Hepatitis B virus infection
2009 Standout
Structure of Dengue Virus
2002 Standout
Vaccines: past, present and future
2005
Foreign gene expression in yeast: a review
1992
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Synthesis of the measles virus nucleoprotein in yeast Pichia pastoris and Saccharomyces cerevisiae
2003
Hepatitis B vaccines
2003
Virus-like particles as HIV-1 vaccines
2004
Participation of cathepsin B in processing of antigen presentation to MHC class II
1993
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose
2011
Generation of Tioman virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae
2009
Multi-protein complexes in the cis Golgi of Saccharomyces cerevisiae with alpha -1,6-mannosyltransferase activity
1998
Self-assembling protein nanoparticles in the design of vaccines
2015
Progress on new vaccine strategies against chronic viral infections
2004
Production and Characterization of Simian-Human Immunodeficiency Virus-Like Particles
2000
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
2013
Applications of viral nanoparticles in medicine
2011
Production of hepatitis B surface antigen in transgenic plants for oral immunization
2000
Assembly of Hepadnaviral Virions and Subviral Particles
1991
The global impact of vaccination against hepatitis B: A historical overview
2008
A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare<sup>®</sup>)
2001
Generation of menangle virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae
2007
Hepatocellular Carcinoma
2011 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways
2008
Complementary Chimeric Isoforms Reveal Dscam1 Binding Specificity In Vivo
2012 StandoutNobel
Collagen: Molecular Diversity in the Body's Protein Scaffold
1980 Science
Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells.
1995 StandoutNobel
Structural patterns in globular proteins
1976 StandoutNatureNobel
High resolution X-ray structure of yeast hexokinase, an allosteric protein exhibiting a non-symmetric arrangement of subunits
1976 StandoutNobel
Regulation of glutamine synthetase, aspartokinase, and total protein turnover in Klebsiella aerogenes
1985
Protein Oxidation and Aging
1992 StandoutScience
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer
2007
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor
1993
AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus
1986 StandoutNobel
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Chemical Glycobiology
2001 StandoutScienceNobel
Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.
1979
Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence
1986 Standout
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Structure of yeast hexokinase
1975 StandoutNobel
Structural characterization of a glycoprotein isolated from alveoli of patients with alveolar proteinosis.
1979
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Functional Expression of a Fungal Laccase in Saccharomyces cerevisiae by Directed Evolution
2003 StandoutNobel
Recombinant Vaccinia Viruses as New Live Vaccines
1984
Synthesis of Connective Tissue Macromolecules by Smooth Muscle
1979
Active recycling of yeast Golgi mannosyltransferase complexes through the endoplasmic reticulum
2000 StandoutNobel
The hepatitis B virus
1985 Nature
Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels
1982 Standout
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission
1987
Vaccines to Prevent Infections by Oncoviruses
2010
Antigen Engineering in Yeast: Synthesis and Assembly of Hybrid Hepatitis B Surface Antigen-Herpes Simplex 1 gD Particles
1985
Defects In The Biochemistry Of Collagen In Diseases Of Connective Tissue
1976
Structure of a complex between yeast hexokinase A and glucose
1980 StandoutNobel
Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion.
1992
Monomer-dimer equilibriums of yeast hexokinase during reacting enzyme sedimentation
1974
Genetic interactions affecting touch sensitivity in Caenorhabditis elegans.
1996 StandoutNobel
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Hepatitis B small surface antigen particles are octahedral
2005
A suppressor mutation in the nematode acting on specific alleles of many genes
1978 StandoutNatureNobel
Polyphenolic Substance of Mytilus edulis : Novel Adhesive Containing L-Dopa and Hydroxyproline
1981 StandoutScience
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
The Threonine‐Sensitive Homoserine Dehydrogenase and Aspartokinase Activities of Escherichia coli K12
1972
Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450 BM3 demethylases
2009 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
High resolution crystal structures of yeast hexokinase complexes with substrates, activators, and inhibitors. Evidence for an allosteric control site.
1977 StandoutNobel
Characterization of Collagen and Its Precursors Synthesized by Rabbit‐Articular‐Cartilage Cells in Various Culture Systems
1976
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Progress on new vaccine strategies against chronic viral infections
2004
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Mechanisms of Suppression
1973
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
L-Threonine Dehydrase as a Model of Allosteric Control Involving Ligand-lnduced Oligomerization
1975
Structure of a complex between yeast hexokinase A and glucose
1980 StandoutNobel
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Agonist-induced increase in apparent β-adrenergic receptor size
1978 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
Biochemical characteristics and biological significance of the genetically-distinct collagens
1976
par-6, a gene involved in the establishment of asymmetry in early C. elegans embryos, mediates the asymmetric localization of PAR-3
1996 StandoutNobel
Works of D. Eugene Wampler being referenced
Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N-linked hyperglycosylation
1994
Human hepatitis B vaccine from recombinant yeast
1984 Nature
Threonine-sensitive aspartokinase-homoserine dehydrogenase complex from Escherichia coli. Subunit stoichiometry and size of the catalytic unit
1972
The effects of aminobutyrate and propionate on arginine levels in Neurospora
1964
Pilot scale purification of α-galactosidase A from Cohn Fraction IV-1 of human plasma
1978
Multiple chemical forms of hepatitis B surface antigen produced in yeast.
1985
Regulation of a metabolic system in vitro: synthesis of threonine from aspartic acid
1976
Two aspartokinases from Escherichia coli. Nature of the inhibition and molecular changes accompanying reversible inactivation
1968
Procollagen: Intermediate Forms Containing Several Types of Peptide Chains and Non-Collagen Peptide Extensions at NH 2 and COOH Ends
1974